Fairman Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Fairman Group's AMGN Position: Q1 2025 in Review
Fairman Group sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2 shares — an estimated $521 sold.
Fairman Group first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.29K in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Fairman Group reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Fairman Group sold 2 Amgen shares in Q1 2025, an estimated $521.
- Fairman Group first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
- Fairman Group's Amgen position peaked at $1.29K in Q3 2024.
- 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.